| 1 | [SID26747101] | Active | Potency | 0.6295 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26747101 | | CID | 1066 | | Outcome | Active | | Potency | 0.6295 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 2 | [SID57260132] | Active | Potency | 0.7079 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 57260132 | | CID | 1066 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID57260132] | Active | Potency | 0.8913 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 57260132 | | CID | 1066 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 4 | [SID57260132] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 57260132 | | CID | 1066 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 5 | [SID11113416] | Active | Potency | 1.7783 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 11113416 | | CID | 1066 | | Outcome | Active | | Potency | 1.7783 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 6 | [SID26747101] | Active | Potency | 1.9953 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26747101 | | CID | 1066 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 7 | [SID90341105] | Active | Potency | 3.5481 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 90341105 | | CID | 1066 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 8 | [SID57260132] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 57260132 | | CID | 1066 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 9 | [SID50104349] | Active | Potency | 14.1254 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation [AID504374, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 50104349 | | CID | 1066 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation | | AID | 504374 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 10 | [SID50104349] | Active | Potency | 14.1254 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation [AID504374, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 50104349 | | CID | 1066 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation | | AID | 504374 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 11 | [SID11113416] | Active | Potency | 89.1251 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 11113416 | | CID | 1066 | | Outcome | Active | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 12 | [SID103193195] | Active | | | Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay [AID521220, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Active | | BioAssay | Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay | | AID | 521220 | | BioAssay type | Literature | | Target | | | PubMed | 17417631 | | Data Table |  |
|
| 13 | [SID11111698] | Active | | | qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction [AID595, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 11111698 | | CID | 1066 | | Outcome | Active | | BioAssay | qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction | | AID | 595 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID11113416] | Active | | | qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction [AID595, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 11113416 | | CID | 1066 | | Outcome | Active | | BioAssay | qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction | | AID | 595 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID11113416] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 11113416 | | CID | 1066 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 16 | [SID11113416] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 11113416 | | CID | 1066 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 17 | [SID26747101] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26747101 | | CID | 1066 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 18 | [SID26747101] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26747101 | | CID | 1066 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 19 | [SID57260132] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 57260132 | | CID | 1066 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 20 | [SID57260132] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 57260132 | | CID | 1066 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 21 | [SID57260132] | Active | | | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) [AID602440, Type: screening] | SENP8 gene product [Homo sapiens] [gi:262118306] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 57260132 | | CID | 1066 | | Outcome | Active | | BioAssay | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) | | AID | 602440 | | BioAssay type | screening | | Target | SENP8 gene product [Homo sapiens] [gi:262118306] | | PubMed | | | Data Table |  |
|
| 22 | [SID103193195] | Unspecified | IC50 | 100 | Tested in vitro for the concentration required to inhibit [3H]CPP radioligand at EAA receptor sites in rat cortical membranes [AID144992, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Tested in vitro for the concentration required to inhibit [3H]CPP radioligand at EAA receptor sites in rat cortical membranes | | AID | 144992 | | BioAssay type | Literature | | Target | | | PubMed | 7523673 | | Data Table |  |
|
| 23 | [SID103193195] | Unspecified | IC50 | 100 | Tested in vitro for the concentration required to inhibit [3H]AMPA radioligand at EAA receptor sites in rat cortical membranes [AID31587, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Tested in vitro for the concentration required to inhibit [3H]AMPA radioligand at EAA receptor sites in rat cortical membranes | | AID | 31587 | | BioAssay type | Literature | | Target | | | PubMed | 7523673 | | Data Table |  |
|
| 24 | [SID103193195] | Unspecified | IC50 | 100 | Compound was evaluated for its ability to displace [3H]Glu/[3H]-AP5 from rat brain membrane [AID144611, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Compound was evaluated for its ability to displace [3H]Glu/[3H]-AP5 from rat brain membrane | | AID | 144611 | | BioAssay type | Literature | | Target | | | PubMed | 1533422 | | Data Table |  |
|
| 25 | [SID103193195] | Unspecified | Ki | 200 | Inhibition of Aeromonas hydrophila beta lactamase CphA by competitive inhibition assay [AID323626, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | Ki | 200 [uM] | | BioAssay | Inhibition of Aeromonas hydrophila beta lactamase CphA by competitive inhibition assay | | AID | 323626 | | BioAssay type | Literature | | Target | | | PubMed | 17307979 | | Data Table |  |
|
| 26 | [SID103193195] | Unspecified | EC50 | 1500 | Effective concentration in vitro as electropharmacological activity in the rat cortical wedge preparation [AID175684, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | EC50 | 1500 [uM] | | BioAssay | Effective concentration in vitro as electropharmacological activity in the rat cortical wedge preparation | | AID | 175684 | | BioAssay type | Literature | | Target | | | PubMed | 7523673 | | Data Table |  |
|
| 27 | [SID103193195] | Unspecified | IC50 | 5000 | Inhibition of 2-oxoglutarate-dependent human JMJD2E in prescence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay [AID344917, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | IC50 | 5000 [uM] | | BioAssay | Inhibition of 2-oxoglutarate-dependent human JMJD2E in prescence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay | | AID | 344917 | | BioAssay type | Literature | | Target | | | PubMed | 18942826 | | Data Table |  |
|
| 28 | [SID103193195] | Unspecified | IC50 | 10000 | Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay [AID344916, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | IC50 | 10000 [uM] | | BioAssay | Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay | | AID | 344916 | | BioAssay type | Literature | | Target | | | PubMed | 18942826 | | Data Table |  |
|
| 29 | [SID103193195] | Unspecified | | | Inhibition of Legionella gormani beta lactamase metallo FEZ1 expressed in Escherichia coli assessed as residual enzyme activity at 100 uM [AID323620, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of Legionella gormani beta lactamase metallo FEZ1 expressed in Escherichia coli assessed as residual enzyme activity at 100 uM | | AID | 323620 | | BioAssay type | Literature | | Target | | | PubMed | 17307979 | | Data Table |  |
|
| 30 | [SID103193195] | Unspecified | | | Inhibition of mushroom tyrosinase at 1 mM after 10 mins [AID566699, Type: Literature] | Polyphenol oxidase 2 [gi:6686057] |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of mushroom tyrosinase at 1 mM after 10 mins | | AID | 566699 | | BioAssay type | Literature | | Target | Polyphenol oxidase 2 [gi:6686057] | | PubMed | 21189019 | | Data Table |  |
|
| 31 | [SID103193195] | Unspecified | | | Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay [AID566701, Type: Literature] | Lethal factor [gi:50402185] |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay | | AID | 566701 | | BioAssay type | Literature | | Target | Lethal factor [gi:50402185] | | PubMed | 21189019 | | Data Table |  |
|
| 32 | [SID103193195] | Unspecified | | | Inhibition of IL4 production in transgenic BALB/c mouse TH2 cells at 500 uM after 48 hrs [AID385990, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of IL4 production in transgenic BALB/c mouse TH2 cells at 500 uM after 48 hrs | | AID | 385990 | | BioAssay type | Literature | | Target | | | PubMed | 18003900 | | Data Table |  |
|
| 33 | [SID103193195] | Unspecified | | | Inhibition of IL5 production in transgenic BALB/c mouse TH2 cells at 500 uM after 48 hrs [AID385994, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of IL5 production in transgenic BALB/c mouse TH2 cells at 500 uM after 48 hrs | | AID | 385994 | | BioAssay type | Literature | | Target | | | PubMed | 18003900 | | Data Table |  |
|
| 34 | [SID103193195] | Unspecified | | | Inhibition of IL13 production in transgenic BALB/c mouse TH2 cells at 500 uM after 48 hrs [AID385998, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of IL13 production in transgenic BALB/c mouse TH2 cells at 500 uM after 48 hrs | | AID | 385998 | | BioAssay type | Literature | | Target | | | PubMed | 18003900 | | Data Table |  |
|
| 35 | [SID103193195] | Unspecified | | | Inhibition of IL10 production in transgenic BALB/c mouse TH2 cells at 500 uM after 48 hrs [AID386002, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of IL10 production in transgenic BALB/c mouse TH2 cells at 500 uM after 48 hrs | | AID | 386002 | | BioAssay type | Literature | | Target | | | PubMed | 18003900 | | Data Table |  |
|
| 36 | [SID103193195] | Unspecified | | | Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid [AID386214, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid | | AID | 386214 | | BioAssay type | Literature | | Target | | | PubMed | 18003900 | | Data Table |  |
|
| 37 | [SID103193195] | Unspecified | | | Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid by ELISA [AID386215, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid by ELISA | | AID | 386215 | | BioAssay type | Literature | | Target | | | PubMed | 18003900 | | Data Table |  |
|
| 38 | [SID103193195] | Unspecified | | | Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid by ELISA [AID386216, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid by ELISA | | AID | 386216 | | BioAssay type | Literature | | Target | | | PubMed | 18003900 | | Data Table |  |
|
| 39 | [SID103193195] | Unspecified | | | Inhibition of Stenotrophomonas maltophilia metallo beta lactamase L1 assessed as residual enzyme activity at 100 uM [AID323619, Type: Literature] | Metallo-beta-lactamase L1 [gi:1705478] |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of Stenotrophomonas maltophilia metallo beta lactamase L1 assessed as residual enzyme activity at 100 uM | | AID | 323619 | | BioAssay type | Literature | | Target | Metallo-beta-lactamase L1 [gi:1705478] | | PubMed | 17307979 | | Data Table |  |
|
| 40 | [SID103193195] | Unspecified | | | Neuroprotective effect evaluated for excitatory amino acid receptor antagonism with the concentration at 1 uL in the corpus striatum of 14 rats with choline acetyltransferase as the marker enzyme. [AID180056, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Neuroprotective effect evaluated for excitatory amino acid receptor antagonism with the concentration at 1 uL in the corpus striatum of 14 rats with choline acetyltransferase as the marker enzyme. | | AID | 180056 | | BioAssay type | Literature | | Target | | | PubMed | 1825114 | | Data Table |  |
|
| 41 | [SID103193195] | Unspecified | | | Neuroprotective effect evaluated for excitatory amino acid receptor antagonism with the concentration at 1 uL in the corpus striatum of 14 rats with glutamic acid decarboxylase as the marker enzyme. [AID180057, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Neuroprotective effect evaluated for excitatory amino acid receptor antagonism with the concentration at 1 uL in the corpus striatum of 14 rats with glutamic acid decarboxylase as the marker enzyme. | | AID | 180057 | | BioAssay type | Literature | | Target | | | PubMed | 1825114 | | Data Table |  |
|
| 42 | [SID103193195] | Unspecified | | | Inhibition of Pseudomonas aeruginosa 101/1477 metallo beta lactamase IMP1 expressed in in Escherichia coli assessed as residual enzyme activity at 100 uM in absence of zinc [AID323613, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of Pseudomonas aeruginosa 101/1477 metallo beta lactamase IMP1 expressed in in Escherichia coli assessed as residual enzyme activity at 100 uM in absence of zinc | | AID | 323613 | | BioAssay type | Literature | | Target | | | PubMed | 17307979 | | Data Table |  |
|
| 43 | [SID103193195] | Unspecified | | | Inhibition of Pseudomonas aeruginosa 101/1477 metallo beta lactamase IMP1 expressed in in Escherichia coli assessed as residual enzyme activity at 100 uM in presence of zinc chloride [AID323614, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of Pseudomonas aeruginosa 101/1477 metallo beta lactamase IMP1 expressed in in Escherichia coli assessed as residual enzyme activity at 100 uM in presence of zinc chloride | | AID | 323614 | | BioAssay type | Literature | | Target | | | PubMed | 17307979 | | Data Table |  |
|
| 44 | [SID103193195] | Unspecified | | | Inhibition of Bacillus cereus metallo beta lactamase Bc2 assessed as residual enzyme activity at 100 uM [AID323615, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of Bacillus cereus metallo beta lactamase Bc2 assessed as residual enzyme activity at 100 uM | | AID | 323615 | | BioAssay type | Literature | | Target | | | PubMed | 17307979 | | Data Table |  |
|
| 45 | [SID103193195] | Unspecified | | | Inhibition of metallo beta lactamase VIM2 assessed as residual enzyme activity at 100 uM [AID323616, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of metallo beta lactamase VIM2 assessed as residual enzyme activity at 100 uM | | AID | 323616 | | BioAssay type | Literature | | Target | | | PubMed | 17307979 | | Data Table |  |
|
| 46 | [SID103193195] | Unspecified | | | Inhibition of metallo beta lactamase VIM4 assessed as residual enzyme activity at 100 uM [AID323617, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of metallo beta lactamase VIM4 assessed as residual enzyme activity at 100 uM | | AID | 323617 | | BioAssay type | Literature | | Target | | | PubMed | 17307979 | | Data Table |  |
|
| 47 | [SID103193195] | Unspecified | | | Inhibition of Aeromonas hydrophila metallo beta lactamase CphA assessed as residual enzyme activity at 100 uM in absence of zinc [AID323618, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Inhibition of Aeromonas hydrophila metallo beta lactamase CphA assessed as residual enzyme activity at 100 uM in absence of zinc | | AID | 323618 | | BioAssay type | Literature | | Target | | | PubMed | 17307979 | | Data Table |  |
|
| 48 | [SID103193195] | Unspecified | | | pKa was determined [AID143257, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103193195 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | pKa was determined | | AID | 143257 | | BioAssay type | Literature | | Target | | | PubMed | 7523673 | | Data Table |  |
|
| 49 | [SID8149825] | Unspecified | | | Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) [AID1612, Type: other] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 8149825 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) | | AID | 1612 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID8149825] | Unspecified | | | Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) [AID1613, Type: other] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 8149825 | | CID | 1066 | | Outcome | Unspecified | | BioAssay | Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) | | AID | 1613 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|